Aruba

Reimbursed Care Access

Aruba maintains a conventional, enforcement-focused drug-control regime: internationally scheduled classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, etc.) are treated as controlled substances with no general authorized medical program outside approved research, while ketamine is available for established medical indications (primarily anesthesia) but psychedelic/psychiatric uses (including esketamine/SPRAVATO®) have very limited to no publicly reimbursed access on-island. Enforcement and prosecutions for illicit possession and trafficking remain a priority of Aruba’s public prosecutor and police services. [https://omaruba.com/jaarverslag-2022/|Openbaar Ministerie Aruba Annual Report 2022].